Ecolab(US:ECL)2025-07-29 17:00Financial Performance - Ecolab's reported diluted EPS was $1.84, with adjusted diluted EPS at $1.89, a 13% increase[7, 12] - The company anticipates full-year 2025 adjusted diluted earnings per share to be in the range of $7.42 to $7.62, representing a 12% to 15% increase compared to 2024[8, 15] - Ecolab projects third-quarter 2025 adjusted diluted earnings per share to be between $2.02 and $2.12, a 10% to 16% rise from the previous year[8, 15] - Reported sales increased by 1%, which includes an unfavorable impact of 2% from the sale of the global surgical solutions business[8] - Organic sales grew by 3%, driven by Institutional & Specialty and Water segments[8] - Reported operating income (OI) increased by 8%, with organic OI rising by 14%[8] - Organic operating income margin expanded by 170 bps to 18.3%, attributed to value pricing and improved productivity[8] Segment Performance - Global Water segment sales increased by 2%[16] - Global Institutional & Specialty segment sales increased by 4%[16] - Global Pest Elimination segment sales increased by 6%[16] - Global Life Sciences segment sales increased by 4%[16] Strategic Outlook - Ecolab expects to achieve a 20% operating income margin by 2027[7] - The company is focused on capitalizing on long-term growth opportunities, maximizing service effectiveness, and leveraging investments in digital technology[37] - Ecolab is well-prepared to manage the dynamic international trade environment through its world-class supply chain, 'local for local' production model, and recently implemented trade surcharge[15]